Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.86 USD | -2.87% | -4.44% | -22.52% |
09/05 | Earnings Flash (CTSO) CYTOSORBENTS Posts Q1 Revenue $9.8M, vs. Street Est of $9.79M | MT |
09/05 | Transcript : Cytosorbents Corporation, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.52% | 48.08M | |
+7.24% | 217B | |
+13.97% | 195B | |
+30.79% | 112B | |
+3.31% | 65.83B | |
+14.24% | 52.67B | |
+2.72% | 49.86B | |
-5.79% | 38.18B | |
-0.48% | 35.39B | |
+22.44% | 31.02B |
- Stock Market
- Equities
- CTSO Stock
- News Cytosorbents Corporation
- Cytosorbents Says STAR-T Trial Enrolls 80 Patients, Reaches Second of Three Milestones